Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio Save Group provides education and access to storage of umbilical cord blood and tissue for expectant parents. As part of the FamiCord Group, it benefits from extensive experience with over 4,500 cell therapies provided by July 2022—including more than 200 releases of cord blood therapies—and participates in clinical research on advanced therapy medicinal products using stored tissues or cells.[3] The group holds relevant accreditations and offers insurance packages supporting global transplant logistics.
Clinical results are primarily related to successful release/use of stored samples for transplantation rather than drug development.
The company also offers guarantees such as free preparation/transportation of samples worldwide if needed for therapy.[3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio Save Group.